Amlexanoxo [Spanish] en es it fr

Amlexanoxo [Spanish] Brand names, Amlexanoxo [Spanish] Analogs

Amlexanoxo [Spanish] Brand Names Mixture

  • No information avaliable

Amlexanoxo [Spanish] Chemical_Formula


Amlexanoxo [Spanish] RX_link

No information avaliable

Amlexanoxo [Spanish] fda sheet

Amlexanoxo_[Spanish] FDA

Amlexanoxo [Spanish] msds (material safety sheet)

Amlexanoxo_[Spanish] MSDS

Amlexanoxo [Spanish] Synthesis Reference

No information avaliable

Amlexanoxo [Spanish] Molecular Weight

298.293 g/mol

Amlexanoxo [Spanish] Melting Point

No information avaliable

Amlexanoxo [Spanish] H2O Solubility

No information avaliable

Amlexanoxo [Spanish] State


Amlexanoxo [Spanish] LogP


Amlexanoxo [Spanish] Dosage Forms

Oral paste (5%, 5g)

Amlexanoxo [Spanish] Indication

Used as a paste in the mouth to treat aphthous ulcers (canker sores).

Amlexanoxo [Spanish] Pharmacology

Amlexanox is a mucoadhesive oral paste which has been clinically proven to abort the onset, accelerate healing and resolve the pain of aphthous ulcers (canker sores). It decreases the time ulcers take to heal. Because amlexanox decreases the healing time, it also decreases the pain you feel. Recent studies have also shown that the majority of ulcers can be prevented by application of the paste during the prodromal (pre-ulcerative) phase of the disease. Recurrent Aphthous Ulcers (RAU) also known as Recurrent Aphthous Stomatitis (RAS) is recognized as the most common oral mucosal disease known to man. Estimates suggest that 20% - 25% of the general population suffer at least one incidence of aphthous ulcers each year.

Amlexanoxo [Spanish] Absorption

No significant absorption directly through the active ulcer. Most of the systemic absorption is via the gastrointestinal tract.

Amlexanoxo [Spanish] side effects and Toxicity

No information avaliable

Amlexanoxo [Spanish] Patient Information

Amlexanoxo [Spanish] Organisms Affected

Humans and other mammals